Agency Forms Undergoing Paperwork Reduction Act Review, 11576-11577 [2017-03593]
Download as PDF
<![CDATA[
11576
Federal Register / Vol. 82, No. 36 / Friday, February 24, 2017 / Notices
Engagement Strategies’’, IP17–002 and
‘‘Rapid-Cycle Survey Collaborative for
Provider Input on Immunization
Issues’’, IP17–003.
CONTACT PERSON FOR MORE INFORMATION:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road, NE., Mailstop E60,
Atlanta, Georgia 30333, Telephone:
(404) 718–8833.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–03628 Filed 2–23–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—State, Tribal, Local and
Territorial (STLT) Subcommittee
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
TIME AND DATE: 10:00 a.m.–11:30 a.m.,
EDT, March 21, 2017.
PLACE: This meeting will be held by
teleconference.
STATUS: This meeting is open to the
public, limited only by the availability
of telephone ports. The public is
welcome to participate during the
public comment, which is tentatively
scheduled from 11:15 a.m.–11:20 a.m.
EDT. To participate on the
teleconference, please dial (855) 644–
0229 and enter code 1482483.
PURPOSE: The Subcommittee will
provide advice to the CDC Director
through the ACD on strategies, future
needs, and challenges faced by State,
Tribal, Local and Territorial health
agencies, and will provide guidance on
opportunities for CDC.
MATTERS FOR DISCUSSION: The STLT
Subcommittee members will discuss
progress on implementation of ACDadopted recommendations related to the
Jkt 241001
Jose Montero, MD, MPH, Designated
Federal Officer, STLT Subcommittee,
ACD, CDC, 4770 Buford Highway, MS
E70, Atlanta, Georgia 30341, Telephone
(404) 498–0300, Email:
OSTLTSDirector@cdc.gov. Please
submit comments to OSTLTSDirector@
cdc.gov no later than March 17, 2017.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
[FR Doc. 2017–03626 Filed 2–23–17; 8:45 am]
Centers for Disease Control and
Prevention
17:20 Feb 23, 2017
CONTACT PERSON FOR MORE INFORMATION:
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
BILLING CODE 4163–18–P
VerDate Sep<11>2014
health department of the future, other
emerging challenges and how CDC can
best support STLT health departments
in the transforming health system.
The agenda is subject to change as
priorities dictate.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–17–0733]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, Washington, DC 20503 or by fax
to (202) 395–5806. Written comments
should be received within 30 days of
this notice.
Proposed Project
Early Hearing Detection and
Intervention (EHDI) Follow-up Survey
(OMB Control No. 0920–0733,
Expiration Date: 8/31/2016)—
Reinstatement with Change—National
Center on Birth Defects and
Developmental Disabilities (NCBDDD),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
NCBDDD promotes the health of
babies, children, and adults, with a
focus on preventing birth defects and
developmental disabilities and
optimizing the health outcomes of those
with disabilities. As part of these efforts
NCBDDD is actively involved in
addressing the early identification of
hearing loss among newborns and
infants. Congenital hearing loss is a
common birth defect that affects 1 to 3
per 1,000 live births, or approximately
12,000 children across the United States
annually. Studies have shown that
children with a delayed diagnosis of
hearing loss can experience preventable
delays in speech, language, and
cognitive development. To ensure
children with hearing loss are identified
as soon as possible, many states and
United States (U.S.) territories have
implemented Early Hearing Detection
and Intervention (EHDI) programs and
enacted laws related to infant hearing
screening. The majority of these EHDI
programs have adopted the ‘‘1–3–6’’
plan, which consists of three core goals:
(1) Screening all infants for hearing loss
before 1 month of age, (2) ensuring
diagnostic audiologic evaluation before
3 months of age for those who do not
pass the screening, and (3) enrollment
E:\FR\FM\24FEN1.SGM
24FEN1
11577
Federal Register / Vol. 82, No. 36 / Friday, February 24, 2017 / Notices
in early intervention services before six
months of age for those identified with
hearing loss.
Federal support for identifying
children with hearing loss began with
the Children’s Health Act of 2000,
which authorized federal programs to
support EHDI activities at the state
level. Since then, funds have been
distributed to states via cooperative
agreements from the CDC and grants
from the Health Resources and Services
Administration (HRSA). States are using
these federal monies to enhance EHDI
programs and develop corresponding
tracking and surveillance systems.
These systems are intended to help
EHDI programs ensure infants and
children are receiving recommended
hearing screening, follow-up, and
intervention services.
The mission of the CDC EHDI team is
for every state and U.S. territory to have
a complete EHDI tracking and
surveillance system that will help
ensure infants and children with
hearing loss achieve communication
and social skills commensurate with
their cognitive abilities. As part of this
mission the CDC EHDI team, in
collaboration with representatives of
state and U.S. territorial EHDI programs,
developed seven National EHDI Goals
that reflect the ‘‘1–3–6 plan’’ and
address integration with the medical
home (coordinated care by a medical
provider) and development of tracking
and surveillance systems to minimize
loss to follow-up and loss to
documentation. Many of the defined
performance indicators for these goals
involve obtaining data related to the
number of children screened for hearing
loss, referred for and receiving followup testing (e.g., diagnostic audiologic
evaluation) and enrolled in early
intervention services.
The purpose of the revised survey is
to obtain annual state data on the
performance indicators in a consistent
manner, which is needed to assess
progress towards meeting the National
EHDI goals. In addition, the availability
of these data will better enable the CDC
EHDI team to provide technical
assistance to states and respond to
questions by the general public, policy
makers, and Healthy People 2020
officials.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
EHDI Program State Program Coordinators Contacted .........
EHDI Program State Program Coordinators who return the
survey.
Survey Directions ...................
Survey ....................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–03593 Filed 2–23–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcements
(FOAs): CK17–001, ‘‘Creation of a
Healthcare-Associated Infectious
Disease Modeling Network to Improve
Prevention Research and Healthcare
Delivery’’; CK17–002, ‘‘Evaluation of
Clinical Interventions, Surveillance, and
Ecological Factors that Influence the
Burden of Human Monkeypox in the
Democratic Republic of the Congo
(DRC)’’; and CK17–004, ‘‘Determining
VerDate Sep<11>2014
17:20 Feb 23, 2017
Jkt 241001
and Monitoring Health Conditions
Identified in the Medical Assessment of
US-Bound Refugees.’’
Time and Date:
10:00 a.m.–5:00 p.m., EDT, March 28–
29, 2017 (Closed)
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Creation of a Healthcare-Associated
Infectious Disease Modeling Network to
Improve Prevention Research and
Healthcare Delivery’’, CK17–001;
‘‘Evaluation of Clinical Interventions,
Surveillance, and Ecological Factors
that Influence the Burden of Human
Monkeypox in the Democratic Republic
of the Congo (DRC)’’, CK17–002; and
‘‘Determining and Monitoring Health
Conditions Identified in the Medical
Assessment of US-Bound Refugees’’,
CK17–004.
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE., Mailstop E60, Atlanta,
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
59
57
Average
burden per
response
(in hours)
1
1
10/60
240/60
Georgia 30333, Telephone: (404) 718–
8833.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–03647 Filed 2–23–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
ICD–10 Coordination and Maintenance
(C&M) Committee Meeting National
Center for Health Statistics (NCHS),
Classifications and Public Health Data
Standards Staff, Announces the
Following Meeting
ICD–10 Coordination and
Maintenance (C&M) Committee meeting.
TIME AND DATE: 9:00 a.m.–5:00 p.m.,
EST, March 7–8, 2017
NAME:
E:\FR\FM\24FEN1.SGM
24FEN1
]]>Agencies
[Federal Register Volume 82, Number 36 (Friday, February 24, 2017)]
[Notices]
[Pages 11576-11577]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03593]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-17-0733]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget,
Washington, DC 20503 or by fax to (202) 395-5806. Written comments
should be received within 30 days of this notice.
Proposed Project
Early Hearing Detection and Intervention (EHDI) Follow-up Survey
(OMB Control No. 0920-0733, Expiration Date: 8/31/2016)--Reinstatement
with Change--National Center on Birth Defects and Developmental
Disabilities (NCBDDD), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
NCBDDD promotes the health of babies, children, and adults, with a
focus on preventing birth defects and developmental disabilities and
optimizing the health outcomes of those with disabilities. As part of
these efforts NCBDDD is actively involved in addressing the early
identification of hearing loss among newborns and infants. Congenital
hearing loss is a common birth defect that affects 1 to 3 per 1,000
live births, or approximately 12,000 children across the United States
annually. Studies have shown that children with a delayed diagnosis of
hearing loss can experience preventable delays in speech, language, and
cognitive development. To ensure children with hearing loss are
identified as soon as possible, many states and United States (U.S.)
territories have implemented Early Hearing Detection and Intervention
(EHDI) programs and enacted laws related to infant hearing screening.
The majority of these EHDI programs have adopted the ``1-3-6'' plan,
which consists of three core goals: (1) Screening all infants for
hearing loss before 1 month of age, (2) ensuring diagnostic audiologic
evaluation before 3 months of age for those who do not pass the
screening, and (3) enrollment
[[Page 11577]]
in early intervention services before six months of age for those
identified with hearing loss.
Federal support for identifying children with hearing loss began
with the Children's Health Act of 2000, which authorized federal
programs to support EHDI activities at the state level. Since then,
funds have been distributed to states via cooperative agreements from
the CDC and grants from the Health Resources and Services
Administration (HRSA). States are using these federal monies to enhance
EHDI programs and develop corresponding tracking and surveillance
systems. These systems are intended to help EHDI programs ensure
infants and children are receiving recommended hearing screening,
follow-up, and intervention services.
The mission of the CDC EHDI team is for every state and U.S.
territory to have a complete EHDI tracking and surveillance system that
will help ensure infants and children with hearing loss achieve
communication and social skills commensurate with their cognitive
abilities. As part of this mission the CDC EHDI team, in collaboration
with representatives of state and U.S. territorial EHDI programs,
developed seven National EHDI Goals that reflect the ``1-3-6 plan'' and
address integration with the medical home (coordinated care by a
medical provider) and development of tracking and surveillance systems
to minimize loss to follow-up and loss to documentation. Many of the
defined performance indicators for these goals involve obtaining data
related to the number of children screened for hearing loss, referred
for and receiving follow-up testing (e.g., diagnostic audiologic
evaluation) and enrolled in early intervention services.
The purpose of the revised survey is to obtain annual state data on
the performance indicators in a consistent manner, which is needed to
assess progress towards meeting the National EHDI goals. In addition,
the availability of these data will better enable the CDC EHDI team to
provide technical assistance to states and respond to questions by the
general public, policy makers, and Healthy People 2020 officials.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
EHDI Program State Program Survey Directions....... 59 1 10/60
Coordinators Contacted.
EHDI Program State Program Survey.................. 57 1 240/60
Coordinators who return the survey.
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-03593 Filed 2-23-17; 8:45 am]
BILLING CODE 4163-18-P
